Short stature caused by SHOX gene haploinsufficiency: From diagnosis to treatment;Baixa estatura por haploinsuficiência do gene SHOX: Do diagnóstico ao tratamento

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 52, Issue 5, 2008, Pages 765-773

  Jorge, Alexander A L ^a   Nishi, Mirian Y ^a   Funari, Mariana F A ^a   Souza, Silvia C ^a   Arnhold, Ivo J P ^a   Mendonça, Berenice B ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Dwarfism diagnostic; Dwarfism genetic; Failure to thrive; Genes homeobox; Growth hormone pharmacology; Growth hormone therapeutic use

Indexed keywords

EID: 51949111362     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302008000500008     Document Type: Review

References (32)

1. Jacobs PA, Harnden DG, Buckton KE, Brown WM, King MJ, Mc BJ, et al. Cytogenetic studies in primary amenorrhoea. Lancet. 1961;1:1183-9.
2. Goldman B, Polani PE, Daker MG, Angell RR. Clinical and cytogenetic aspects of X-chromosome deletions. Clin Genet. 1982;21:36-52.
3. Fisher EM, Beer-Romero P, Brown LG, Ridley A, McNeil JA, Lawrence JB, et al. Homologous ribosomal protein genes on the human X and Y chromosomes: escape from X inactivation and possible implications for Turner syndrome. Cell. 1990;63:1205-18.
4. Rouyer F, Simmler MC, Johnsson C, Vergnaud G, Cooke HJ, Weissenbach J. A gradient of sex linkage in the pseudoautosomal region of the human sex chromosomes. Nature. 1986;319:291-5.
5. Rao E, Weiss B, Fukami M, Rump A, Niesler B, Mertz A, et al. Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome. Nat Genet. 1997;16:54-63.
6. Blaschke RJ, Rappold GA. SHOX: growth, Leri-Weill and Turner syndromes. Trends Endocrinol Metab. 2000;11:227-30.
7. Blaschke RJ, Topfer C, Marchini A, Steinbeisser H, Janssern JW, Rappold GA. Transcriptional and translational regulation of the Leri-Weill and Turner syndrome homeobox gene SHOX. J Biol Chem. 2003;278:47820-6.
8. Rao E, Blaschke RJ, Marchini A, Niesler B, Burnett M, Rappold GA. The Leri-Weill and Turner syndrome homeobox gene SHOX encodes a cell-type specific transcriptional activator. Hum Mol Genet. 2001;10:3083-91.
9. Munns CJ, Haase HR, Crowther LM, Hayes MT, Blaschke R, Rappold G, et al. Expression of SHOX in human fetal and childhood growth plate. J Clin Endocrinol Metab. 2004;89:4130-5.
10. Thomas NS, Maloney V, Bass P, Mulik V, Wellesley D, Castle B. SHOX mutations in a family and a fetus with Langer mesomelic dwarfism. Am J Med Genet. 2004; 128A:179-84.
11. Binder G, Eggermann T, Enders H, Ranke MB, Dufke A. Tall stature, gonadal dysgenesis, and stigmata of Turner's syndrome caused by a structurally altered X chromosome. J Pediatr. 2001;138:285-7.
12. Binder G, Renz A, Martinez A, Keselman A, Hesse V, Riedl SW, et al. SHOX haploinsufficiency and Leri-Weill dyschondrosteosis: prevalence and growth failure in relation to mutation, sex, and degree of wrist deformity. J Clin Endocrinol Metab. 2004;89:4403-8.
13. Belin V, Cusin V, Viot G, Girlich D, Toutain A, Moncla A, et al. SHOX mutations in dyschondrosteosis (Leri-Weill syndrome). Nat Genet. 1998;19:67-9.
14. Kosho T, Muroya K, Nagai T, Fujimoto M, Yokoya S, Sakamoto H, et al. Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX: implications for the development of Turner syndrome. J Clin Endocrinol Metab. 1999;84:4613-21.
15. Ross JL, Scott C Jr., Marttila P, Kowal K, Nass A, Papenhausen P, et al. Phenotypes associated with SHOX deficiency. J Clin Endocrinol Metab. 2001;86:5674-80.
16. Binder G, Ranke MB, Martin DD. Auxology is a valuable instrument for the clinical diagnosis of SHOX haploinsufficiency in school-age children with unexplained short stature. J Clin Endocrinol Metab. 2003;88:4891-6.
17. Jorge AA, Souza SC, Nishi MY, Billerbeck AE, Liborio DC, Kim CA, et al. SHOX mutations in idiopathic short stature and Leri-Weill dyschondrosteosis: frequency and phenotypic variability. Clin Endocrinol (Oxf). 2007;66:130-5.
18. Rappold G, Blum WF, Shavrikova EP, Crowe BJ, Roeth R, Quigley CA, et al. Genotypes and phenotypes in children with short stature: clinical indicators of SHOX haploinsufficiency. J Med Genet. 2007;44:306-13.
19. a ed. Universitaire Pers Maastricht, Maastricht; 2001
20. Shears DJ, Vassal HJ, Goodman FR, Palmer RW, Reardon W, Superti-Furga A, et al. Mutation and deletion of the pseudoautosomal gene SHOX cause Leri-Weill dyschondrosteosis. Nat Genet. 1998;19:70-3.
21. Schiller S, Spranger S, Schechinger B, Fukami M, Merker S, Drop SL, et al. Phenotypic variation and genetic heterogeneity in Leri-Weill syndrome. Eur J Hum Genet. 2000;8:54-62.
22. Binder G, Schwarze CP, Ranke MB. Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone. J Clin Endocrinol Metab. 2000;85:245-9.
23. Stuppia L, Calabrese G, Gatta V, Pintor S, Morizio E, Fantasia D, et al. SHOX mutations detected by FISH and direct sequencing in patients with short stature. J Med Genet. 2003;40:E11.
24. Huber C, Rosilio M, Munnich A, Cormier-Daire V. High incidence of SHOX anomalies in individuals with short stature. J Med Genet. 2006; 43:735-9.
25. Grigelioniene G, Schoumans J, Neumeyer L, Ivarsson A, Eklof O, Enkvist O, et al. Analysis of short stature homeobox-containing gene ( SHOX) and auxological phenotype in dyschondrosteosis and isolated Madelung deformity. Hum Genet. 2001;109:551-8.
26. Falcinelli C, Iughetti L, Percesepe A, Calabrese G, Chiarelli F, Cisternino M, et al. SHOX point mutations and deletions in Leri-Weill dyschondrosteosis. J Med Genet. 2002;39:E33.
27. Flanagan SF, Munns CF, Hayes M, Williams B, Berry M, Vickers D, et al. Prevalence of mutations in the short stature homeobox containing gene (SHOX) in Madelung deformity of childhood. J Med Genet. 2002;39:758-63.
28. Benito-Sanz S, Thomas NS, Huber C, Gorbenko del Blanco D, Aza-Carmona M, Crolla JA, et al. A novel class of Pseudoautosomal region 1 deletions downstream of SHOX is associated with Leri-Weill dyschondrosteosis. Am J Hum Genet. 2005;77:533-44.
29. Fukami M, Kato F, Tajima T, Yokoya S, Ogata T. Transactivation function of an approximately 800-bp evolutionarily conserved sequence at the SHOX 3' region: implication for the downstream enhancer. Am J Hum Genet. 2006;78:167-70.
30. Blum WF, Crowe BJ, Quigley CA, Jung H, Cao D, Ross JL, et al. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: two-year results of a randomized, controlled, multicenter trial. J Clin Endocrinol Metab. 2007;92:219-28.
31. Fukami M, Nishi Y, Hasegawa Y, Miyoshi Y, Okabe T, Haga N, et al. Statural growth in 31 Japanese patients with SHOX haploinsufficiency: support for a disadvantageous effect of gonadal estrogens. Endocr J. 2004;51:197-200.
32. Ogata T, Onigata K, Hotsubo T, Matsuo N, Rappold G. Growth hormone and gonadotropin-releasing hormone analog therapy in haploinsufficiency of SHOX. Endocr J. 2001;48:317-22.